AMSTERDAM, February 20 /PRNewswire/ --

- Conference Call & Webcast Today at 10:00 CET

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its full year 2007 results.

Highlights

- Successful IPO, raising gross proceeds of EUR 55.7 million

- Cash & cash equivalents of EUR 51.3 million at June 30, 2007

- U.S. FDA orphan drug designation for lead product AMT 011

- Positive results of Phase I/II in LPL type I deficiency

- Pre-registration trial in Canada on track

- Appointment of Ferdinand Verdonck as chairman of supervisory board.

- Global rights for acute intermittent porphyria treatment

- Exclusive license to all gene therapy products from CIMA

Scientists from four well-known institutions say the next major disease like HIV/AIDS or SARS could occur in any of a number of developing countries concentrated along the equator. They encourage increased surveillance to prevent the spread of a potential outbreak.

Using global databases and sophisticated computer models to analyze patterns of emerging diseases, the researchers -- from the Consortium for Conservation Medicine (CCM) at Wildlife Trust, N.Y., the Institute of Zoology, London, U.K., Columbia University, N.Y., and the University of Georgia, Athens, Ga.

Dr. Tom Hansen has a vision for clean power. It’s big and bold. Dubbed the ‘Hansen Plan’ in a January 2008 Scientific American article, it would completely replace fossil fuels and nuclear power generation across the country. The idea is gaining fervent followers for its seeming simplicity, and equally passionate detractors for the cost and effort required to implement it.

At first blush Dr. Hansen seems an unlikely visionary. The mild, even humble manner, worn running shoes, plaid shirt and rumpled khakis belong to a man who doesn’t mind getting his hands dirty. For years he ran coal-fired power plants for Tucson Electric Power, now serving almost four hundred thousand customers in Arizona. Not having much to do because the plants “ran themselves,” he started researching how to transform TEP and the industry. In the early 90s he quit running the coal plants to focus on renewables, and is now TEP’s Vice President of Environmental Services, Conservation and Renewable Energy.

Last week I chatted with Dr. Hansen at TEP’s bustling Green Team office. We talked about the company’s goals, the Hansen Plan, state of the art energy storage, plug-in hybrids and the new Smart Grid demo projects, as well as his concerns about natural gas. He also reveals his pick for the best thin film solar panels . They may be less efficient but are becoming less expensive than the standard silicon-based ones, which he calls “crystallines”.

LONDON, February 19 /PRNewswire/ --

Northrop Grumman Corporation (NYSE: NOC) continues to grow its international business in remote control vehicles for explosive ordnance disposal (EOD) with recent sales of its Revolution vehicles across the Asia and Asia Pacific regions.

A photo accompanying this release is available at: http://media.primezone.com/noc/

BRACKNELL, England, February 19 /PRNewswire/ -- Monday's BBC Panorama programme highlighted the environmental cost of drinking bottled water and interviewed environment minister Phil Woolas who urged UK consumers and businesses to rethink their choices. The programme also featured a meeting at the Department for Environment, Food and Rural Affairs (DEFRA) where tap water was served in a jug.

LONDON, February 19 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the digital 'front door' to the NHS, launches a new interactive tool aimed to help people assess their drinking behaviour and improve their understanding of safe limits for sensible drinking.

Based on NHS accredited information, the drinking assessment tool (http://www.nhs.uk/Tools/Pages/Alcoholcalculator.aspx?Tag=) enables users to find out in seconds whether they are drinking too much, and provides them with clinically approved guidance on cutting down or seeking advice if they are concerned about their behaviour. This interactive tool is the latest addition to the NHS Choices' extensive tool library.

ROME, February 19 /PRNewswire/ --

- TIBCO ActiveMatrix(TM) Platform-Independent Approach Delivers Up to 49 Percent Greater Productivity Compared to Oracle, IBM, and BEA

BUDAPEST, Hungary, February 19 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics today announced the launch of version 5 of their cheminformatics toolkits, Marvin & JChem. The release sees major improvement in Marvin user friendliness, Markush enumeration and core development in JChem search, clustering and Oracle Cartridge performance.

SAN JOSE, California, February 19 /PRNewswire/ --

Atmel(R) Corporation (Nasdaq: ATML) and SEGGER Microcontroller, a leading manufacturer of middleware for embedded systems, announced today the availability of the real time operating system (OS) embOS for the AVR(R)32 microcontrollers.

The modern AVR32 architecture from Atmel is specially crafted to meet RTOS requirements with its fast multilevel interrupt controller, memory protection unit and the support for nested interrupts. Having an outstanding energy efficiency of 1.08 DMIPS/MHz and delivering up to 83 Dhrystone MIPS (DMIPS) performance at 66 MHz running from embedded flash the UC3 parts are among the highest performance flash microcontrollers in the market today.